Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Screening and treatment for tuberculosis in a cohort of unaccompanied minor refugees in Berlin, Germany.

Thee S, Krüger R, von Bernuth H, Meisel C, Kölsch U, Kirchberger V, Feiterna-Sperling C.

PLoS One. 2019 May 21;14(5):e0216234. doi: 10.1371/journal.pone.0216234. eCollection 2019.

2.

Clinical and Cardiac Safety of Long-term Levofloxacin in Children Treated for Multidrug-resistant Tuberculosis.

Garcia-Prats AJ, Draper HR, Finlayson H, Winckler J, Burger A, Fourie B, Thee S, Hesseling AC, Schaaf HS.

Clin Infect Dis. 2018 Nov 13;67(11):1777-1780. doi: 10.1093/cid/ciy416.

PMID:
29788331
3.

Levofloxacin Population Pharmacokinetics in South African Children Treated for Multidrug-Resistant Tuberculosis.

Denti P, Garcia-Prats AJ, Draper HR, Wiesner L, Winckler J, Thee S, Dooley KE, Savic RM, McIlleron HM, Schaaf HS, Hesseling AC.

Antimicrob Agents Chemother. 2018 Jan 25;62(2). pii: e01521-17. doi: 10.1128/AAC.01521-17. Print 2018 Feb.

4.

[Consensus-Based Guidelines for Diagnosis, Prevention and Treatment of Tuberculosis in Children and Adolescents - A Guideline on Behalf of the German Society for Pediatric Infectious Diseases (DGPI)].

Feiterna-Sperling C, Brinkmann F, Adamczick C, Ahrens F, Barker M, Berger C, Berthold LD, Bogyi M, von Both U, Frischer T, Haas W, Hartmann P, Hillemann D, Hirsch FW, Kranzer K, Kunitz F, Maritz E, Pizzulli A, Ritz N, Schlags R, Spindler T, Thee S, Weizsäcker K.

Pneumologie. 2017 Oct;71(10):629-680. doi: 10.1055/s-0043-116545. Epub 2017 Oct 10. German.

PMID:
29017219
5.

Postexposure prophylaxis with intravenous immunoglobulin G prevents infants from getting measles.

Lejeune A, Martin L, Santibanez S, Thee S, Gratopp A, Späth P, Mankertz A, Kallinich T, von Bernuth H.

Acta Paediatr. 2017 Jan;106(1):174-177. doi: 10.1111/apa.13634. No abstract available.

PMID:
27748542
6.

Activity-Based Probes for 15-Lipoxygenase-1.

Eleftheriadis N, Thee SA, Zwinderman MR, Leus NG, Dekker FJ.

Angew Chem Int Ed Engl. 2016 Sep 26;55(40):12300-5. doi: 10.1002/anie.201606876. Epub 2016 Sep 9.

7.

Adverse effects of oral second-line antituberculosis drugs in children.

Schaaf HS, Thee S, van der Laan L, Hesseling AC, Garcia-Prats AJ.

Expert Opin Drug Saf. 2016 Oct;15(10):1369-81. doi: 10.1080/14740338.2016.1216544. Epub 2016 Aug 5. Review.

PMID:
27458876
8.

A review of the use of ethionamide and prothionamide in childhood tuberculosis.

Thee S, Garcia-Prats AJ, Donald PR, Hesseling AC, Schaaf HS.

Tuberculosis (Edinb). 2016 Mar;97:126-36. doi: 10.1016/j.tube.2015.09.007. Epub 2015 Oct 19. Review.

PMID:
26586647
9.

Pharmacokinetics and Safety of Ofloxacin in Children with Drug-Resistant Tuberculosis.

Garcia-Prats AJ, Draper HR, Thee S, Dooley KE, McIlleron HM, Seddon JA, Wiesner L, Castel S, Schaaf HS, Hesseling AC.

Antimicrob Agents Chemother. 2015 Oct;59(10):6073-9. doi: 10.1128/AAC.01404-15. Epub 2015 Jul 20.

10.

Fluoroquinolones for the treatment of tuberculosis in children.

Thee S, Garcia-Prats AJ, Donald PR, Hesseling AC, Schaaf HS.

Tuberculosis (Edinb). 2015 May;95(3):229-45. doi: 10.1016/j.tube.2015.02.037. Epub 2015 Feb 14. Review.

PMID:
25797610
11.

Identification of 6-benzyloxysalicylates as a novel class of inhibitors of 15-lipoxygenase-1.

Eleftheriadis N, Thee S, te Biesebeek J, van der Wouden P, Baas BJ, Dekker FJ.

Eur J Med Chem. 2015 Apr 13;94:265-75. doi: 10.1016/j.ejmech.2015.03.007. Epub 2015 Mar 5.

PMID:
25771032
12.

Affinity and kinetics study of anthranilic acids as HCA2 receptor agonists.

van Veldhoven JP, Liu R, Thee SA, Wouters Y, Verhoork SJ, Mooiman C, Louvel J, IJzerman AP.

Bioorg Med Chem. 2015 Jul 15;23(14):4013-25. doi: 10.1016/j.bmc.2015.02.018. Epub 2015 Feb 17.

PMID:
25737085
13.

Pharmacokinetics and safety of moxifloxacin in children with multidrug-resistant tuberculosis.

Thee S, Garcia-Prats AJ, Draper HR, McIlleron HM, Wiesner L, Castel S, Schaaf HS, Hesseling AC.

Clin Infect Dis. 2015 Feb 15;60(4):549-56. doi: 10.1093/cid/ciu868. Epub 2014 Oct 30.

14.

Pharmacokinetics of ofloxacin and levofloxacin for prevention and treatment of multidrug-resistant tuberculosis in children.

Thee S, Garcia-Prats AJ, McIlleron HM, Wiesner L, Castel S, Norman J, Draper HR, van der Merwe PL, Hesseling AC, Schaaf HS.

Antimicrob Agents Chemother. 2014 May;58(5):2948-51. doi: 10.1128/AAC.02755-13. Epub 2014 Feb 18.

15.

Population pharmacokinetics of rifampicin, pyrazinamide and isoniazid in children with tuberculosis: in silico evaluation of currently recommended doses.

Zvada SP, Denti P, Donald PR, Schaaf HS, Thee S, Seddon JA, Seifart HI, Smith PJ, McIlleron HM, Simonsson US.

J Antimicrob Chemother. 2014 May;69(5):1339-49. doi: 10.1093/jac/dkt524. Epub 2014 Jan 31.

16.

Hearing loss in children treated for multidrug-resistant tuberculosis.

Seddon JA, Thee S, Jacobs K, Ebrahim A, Hesseling AC, Schaaf HS.

J Infect. 2013 Apr;66(4):320-9. doi: 10.1016/j.jinf.2012.09.002. Epub 2012 Sep 6.

PMID:
22960077
17.

Pharmacokinetics of isoniazid, rifampin, and pyrazinamide in children younger than two years of age with tuberculosis: evidence for implementation of revised World Health Organization recommendations.

Thee S, Seddon JA, Donald PR, Seifart HI, Werely CJ, Hesseling AC, Rosenkranz B, Roll S, Magdorf K, Schaaf HS.

Antimicrob Agents Chemother. 2011 Dec;55(12):5560-7. doi: 10.1128/AAC.05429-11. Epub 2011 Oct 3.

18.

Abnormal thyroid function tests in children on ethionamide treatment.

Thee S, Zöllner EW, Willemse M, Hesseling AC, Magdorf K, Schaaf HS.

Int J Tuberc Lung Dis. 2011 Sep;15(9):1191-3, i. doi: 10.5588/ijtld.10.0707.

PMID:
21943844
19.

Pharmacokinetics of ethionamide in children.

Thee S, Seifart HI, Rosenkranz B, Hesseling AC, Magdorf K, Donald PR, Schaaf HS.

Antimicrob Agents Chemother. 2011 Oct;55(10):4594-600. doi: 10.1128/AAC.00379-11. Epub 2011 Jul 25.

20.

Isoniazid pharmacokinetic studies of the 1960s: considering a higher isoniazid dose in childhood tuberculosis.

Thee S, Detjen AA, Wahn U, Magdorf K.

Scand J Infect Dis. 2010 Apr;42(4):294-8. doi: 10.3109/00365540903493731.

PMID:
20100111
21.

Rifampicin serum levels in childhood tuberculosis.

Thee S, Detjen A, Wahn U, Magdorf K.

Int J Tuberc Lung Dis. 2009 Sep;13(9):1106-11.

PMID:
19723399
22.

Pyrazinamide serum levels in childhood tuberculosis.

Thee S, Detjen A, Wahn U, Magdorf K.

Int J Tuberc Lung Dis. 2008 Sep;12(9):1099-101.

PMID:
18713511
23.

Ethambutol in paediatric tuberculosis: aspects of ethambutol serum concentration, efficacy and toxicity in children.

Thee S, Detjen A, Quarcoo D, Wahn U, Magdorf K.

Int J Tuberc Lung Dis. 2007 Sep;11(9):965-71.

PMID:
17705973
24.

Murine and scrub typhus at Thai-Kampuchean border displaced persons camps.

Wilde H, Pornsilapatip J, Sokly T, Thee S.

Trop Geogr Med. 1991 Oct;43(4):363-9.

PMID:
1812601

Supplemental Content

Support Center